从血管旁路移植术治疗症状性颈内动脉和大脑中动脉闭塞研究(CMOSS)看围手术期管理及血管旁路移植术的未来  

Perioperative management and future of bypass surgery from the research of the carotid and middle cerebral artery occlusion surgery study(CMOSS)

作　　者：郝继恒[1] 司俊臣 张利勇[1] 王继跃[1] Hao Jiheng;Si Junchen;Zhang Liyong;Wang Jiyue(Liaocheng People′s Hospital,Shandong 252000,China)

机构地区：[1]山东省聊城市人民医院神经外科,252000

出　　处：《中国脑血管病杂志》2024年第1期9-13,共5页Chinese Journal of Cerebrovascular Diseases

摘　　要：血管旁路移植术治疗症状性颈内动脉或大脑中动脉血管闭塞的疗效一直备受争议。由中国发起的血管旁路移植术治疗症状性颈内动脉和大脑中动脉闭塞研究(CMOSS)最终取得阴性结果,但这并不能否定血管旁路移植术对症状性血管闭塞患者的治疗价值,而是预示着其临床应用需进一步地深入研究。该文对CMOSS结果进行了分析,对该类患者的围手术期管理进行了总结,介绍了下一步开展的CMOSS2,并探讨了血管旁路移植术的未来,以期为血管旁路移植术临床研究和实践提供参考。The efficacy of bypass surgery in the treatment of symptomatic carotid artery and middle cerebral artery occlusion has been controversial.The Chinese-sponsored study of the carotid and middle cerebral artery occlusion surgery study(CMOSS)ultimately yielded negative results.However,this does not negate the therapeutic value of bypass surgery for patients with symptomatic vascular occlusion.It indicates the need for further in-depth study.This article analyzes the results of the CMOSS study,summarizes knowledge related to perioperative management,and introduces the CMOSS2 study which will be carried out in the next.It also discusses the future of bypass surgery,with the aim of providing a reference for future clinical research and practice.

关 键 词：颈内动脉闭塞 大脑中动脉闭塞 血管旁路移植术 专家论坛 

分 类 号：R651.12[医药卫生—外科学]